Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
100
days
Timing of Second-Line Nivolumab and Survival in Metastatic Renal Cell Carcinoma
AuthorsUğur Özberk; Fahriye Tuğba Köş; Perihan Perkin; Öznur Bal; Berkay Yeşilyurt; Mehmet Akif Parlar; Serkan Delen; Bülent Yalçın
AffiliationsDepartment Of Medical Oncology, Ankara City Hospital, Ankara, Türkiye; Department of Internal Medicine, Ankara City Hospital, Ankara, Türkiye
76
days
Impact of Gleason Grade at the Positive Surgical Margin on Biochemical Recurrence After Radical Prostatectomy in pT2N0 Prostate Cancer
AuthorsMehdi Kardoust Parizi; Akihiro Matsukawa; Ichiro Tsuboi; Pawel Rajwa; Stephan Korn; Heidemarie Ofner; Pierre I. Karakiewicz; Leonardo Oliveira Reis; Marcin Miszczyk; Nicolai Huebner; Giancarlo Marra; Piotr Chlosta; Michael S. Leapman; Shahrokh F. Shariat
AffiliationsDepartment of Urology, Austrian Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran; Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran; Department of Urology, Jikei University School of Medicine, Tokyo, Japan; Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Department of Urology, Medical University of Silesia, Zabrze, Poland; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; UroScience, School of Medical Sciences, State University of Campinas, Campinas, Sao Paulo, Brazil; ImmunOncology, School of Life Sciences, Pontifical Catholic University of Campinas, Campinas, Sao Paulo, Brazil; INCT UroGen, National Institute of Science, Technology and Innovation in Urogenital Cancer, Campinas, Sao Paulo, Brazil; Collegium Medicum—Faculty of Medicine, WSB University, Dąbrowa Górnicza, Poland; Division of Urology, Department of Surgical Sciences, Città della Salute e della Scienza and University of Turin, Turin, Italy; Department of Urology, Jagiellonian University Medical College, Kraków, Poland; Department of Urology, Yale School of Medicine, New Haven, CT; Department of Urology, Weill Cornell Medicine, New York, NY; Department of Urology, University of Texas Southwestern, Dallas, TX; College of Medical Health Technologies, Al-Turath University, Mansour, Baghdad, Iraq; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan; Institute for Urology and Reproductive Health, I.M. Sechenov First Moscow State Medical University, Moscow, Russia; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria
54
days
Definitive Chemoradiotherapy Versus Radical Cystectomy for Small Cell Carcinoma of the Bladder: A Multicenter Retrospective Study
AuthorsHyun Ju Kim; Won Park; Young Seok Kim; Jae-Sung Kim; Youngkyong Kim; Tae Gyu Kim; Sung Uk Lee; Ah Ram Chang; Jaeho Cho
AffiliationsDepartment of Radiation Oncology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea; Department of Radiation Oncology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea; Department of Radiation Oncology, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Korea; Department of Radiation Oncology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; The Proton Therapy Center, National Cancer Center, Research Institute and Hospital, Goyang, Korea; Department of Radiation Oncology/Cyberknife Center, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea; Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
263
days
Nomograms for Predicting Recurrence and Oncologic Outcomes After Partial Nephrectomy for Renal Cell Carcinoma
AuthorsVinícius Luiz Menezes Jesus; Gabriel Carvalho dos Anjos; Gabriel Kledeglau Jahchan Alves; Edgar Alexandre Aviles Sandoval; Guilherme Garcia Barros; David Hamilton Cho; Francisco Valdez Santos Lima; Paulo Afonso de Carvalho; Fabio Pescarmona Gallucci; Leonardo Cardili; Jose Pontes; William Carlos Nahas; Mauricio Dener Cordeiro
AffiliationsDepartment of Urology, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil; Department of Clinical Research, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil; Division of Urology, Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil
34
days
Prognostic Value of Double-expressor Phenotype and an Exploratory DEP-IPI Risk Model in Primary Testicular Diffuse Large B-cell Lymphoma: A Multicenter Retrospective Cohort Study
AuthorsSongqiang Cao; Mengmeng Liu; Chenyang Wang; Xiaolei Zhao; Zhenhua Zhao; Junqing Hou; Jianhua Zhang
AffiliationsDepartment of Urology, Huaihe Hospital of Henan University, Kaifeng, China; Department of Urology, Kaifeng 155 Hospital, China RongTong Medical Healthcare Group Co. Ltd., Kaifeng, China; Department of Urology, Ma’anshan 86 Hospital, China RongTong Medical Healthcare Group Co. Ltd., Ma’anshan, China; Department of Psychiatry, Kaifeng 155 Hospital, China RongTong Medical Healthcare Group Co.Ltd., Kaifeng, China
85
days
Tumor Mutational Burden Predicts the Outcome of Patients With Muscle-invasive bladder Cancer Undergoing Immune-checkpoint Inhibitor-Based Neoadjuvant Therapy
AuthorsChiara Mercinelli; Giuseppe Basile; Giovanni L. Pastorino; Antonio Cigliola; Brigida A. Maiorano; Valentina Tateo; Michela Piacentini; Debora Serafin; Gualtiero Guandalini; Roberta Lacava; Gaia Latini; Maurizio Colecchia; Alberto Briganti; Marco Moschini; Francesco Montorsi; Dean Pavlick; Jeffrey S. Ross; Andrea Necchi
AffiliationsUniversità Vita-Salute San Raffaele, Milan, Italy; Medical Oncology Department, Comprehensive Cancer Center, IRCCS San Raffaele Hospital, Milan, Italy; Urology Department, The Royal Free London Foundation Trust, London, UK; Urology Department, IRCCS Ospedale San Raffaele, Milan, Italy; Medical Oncology Unit 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy; Department of Pathology and Laboratory Medicine, IRCCS Ospedale San Raffaele, Milan, Italy; Foundation Medicine Inc, Cambridge, MA; Upstate Medical University, Syracuse, NY
82
days
Age at Diagnosis and Postoperative Outcomes Among Men Treated for Prostate Cancer in the U.S. Military Health System
AuthorsMolly R. Oroho; Christian Dide-Agossou; Sean Q. Kern; Andrea A. Almeida; Sarah Darmon; Craig D. Shriver; Kangmin Zhu; Yvonne L. Eaglehouse
AffiliationsDepartment of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MA; Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MA; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MA
30
days
Transient PSA Suppression Without Survival Benefit: Real-World Comparative Effectiveness of Cabazitaxel Plus Carboplatin in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
AuthorsAhmad Basharat; Muhammad Shaheer Mannan; Muhammad Raffey Shabbir; Muhammad Waqas Khan; Tuba Basit; Robin Park; Juskaran Chadha; Moazzam Shahzad
AffiliationsDepartment of Internal Medicine, Marshfield Clinic Health System, Marshfield, WI; Department of Internal Medicine, Medical University of South Carolina, Charleston, SC; Department of Internal Medicine, Dow University of Health Sciences, Karachi, Pakistan; Department of Hematology and Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; Department of Hematology and Oncology, University of South Florida, Tampa, FL
72
days
Treatment Patterns and Survival Outcomes in a Real-World Cohort of Lutetium 177 Vipivotide Tetraxetan (LuPSMA)-Experienced Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC)
AuthorsBen Tran; Tanya Dorff; Madeline Richey; Eunice Hankinson; Patrick Olsen; Smriti Karwa; Jason Sharpe; Megan Braunlin; Christopher Kim
AffiliationsPeter MacCallum Cancer Centre Department of Oncology, 305 Grattan Street, Melbourne, Victoria, 3000, Australia; City of Hope Department of Medical Oncology and Therapeutics Research, 1500 East Duarte Road, 91010, CA; Flatiron Health, 233 Spring St, 5th Floor, New York, NY, 10013; Amgen Center for Observational Research, Thousand Oaks, California, United States One Amgen Center Drive, CA 91320
54
days
Multidistance Peritumoral Radiomics With Intratumoral Radiomics Integration Nomogram for Differentiating Fat-Poor Angiomyolipoma From Clear Cell Renal Cell Carcinoma in Discordant and Indeterminate Cases
AuthorsYue Xiao; Xupeng Ye; Huchao Mao; Runfei Zheng; Shuyao Chen; Xiaoying Du; Rendang Bao; Yuhan Chen; Mei Yang; Yan Zhang; Guoquan Cao
AffiliationsDepartment of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Department of Urology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days